Skip to content
Screener

Staar Surgical STAA Restructuring Costs And Asset Impairment Charges

Restructuring Costs And Asset Impairment Charges at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%
SIL
SILASILA
$0-100%
ALH
Alliance Laundry Holdings Inc.ALH
$0-100%
Resideo Technologies, Inc. logo
Resideo Technologies, Inc.REZI
$6M+50.0%
Jones Lang LaSalle logo
Jones Lang LaSalleJLL
$5.3M-73.1%
Pitney Bowes logo
Pitney BowesPBI
$3.34M-75.8%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.15B-13.0%
Enterprise value$1.06B-11.7%
P/S-1.9×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCostsAndAssetImpairmentCharges.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemThree Months Ended / April 3, 2026Three Months Ended / March 28, 2025
Selling and marketing24,50926,945
Research and development9,92511,339
Merger transaction and related costs6,743
Restructuring, impairment and related charges2,68122,664
Total selling, general and administrative expenses60,88085,406
Operating income (loss)7,979(57,401)
Other income (expense), net:
Interest income, net9071,366

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's restructuring costs and asset impairment charges?
Staar Surgical (STAA) reported restructuring costs and asset impairment charges of $2.68M in Q1 2026.
How has Staar Surgical's restructuring costs and asset impairment charges changed year-over-year?
Staar Surgical's restructuring costs and asset impairment charges decreased by 88.2% year-over-year, from $22.66M to $2.68M.
What does restructuring costs and asset impairment charges mean?
This metric captures expenses associated with organizational realignment, such as severance, facility closures, and the write-down of assets that have lost their carrying value. It reflects management's efforts to streamline operations or respond to shifts in market demand. High or recurring values may indicate operational inefficiencies or a need to adjust the company's asset base to current market realities.

Ask your AI about Staar Surgical's restructuring costs and asset impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude